Save your place

Sign in to WhoBought

Please try again later.

enGene Holdings Inc. (ENGN) institutional ownership

Latest close $1.85 Jul 22, 2026
Market cap$196M 52-week range SectorHealthcare
Funds holding · Q1 2026
54
reported ENGN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
33 buyers · 21 sellers

enGene Holdings Inc. (ENGN) price and institutional activity

Dates

Q1 2026

$0 bought by 33 investors
Siren, L.L.C.Balyasny Asset Management L.P. +31 more
$0 sold by 21 investors
Cormorant Asset Management, LPJanus Henderson Group PLC +19 more
Bought Sold Totals per quarter; hover a bar for the names.

enGene Holdings Inc. (ENGN) institutional activity · 54

Investor Type Est. change Change Δ Own Date
Cormorant Asset Management, LP · Exited
Change −4.0M Δ Own −100.0% Date Q1 2026
Cormorant Asset Management, LP Exited· Q1 2026 −4.0M −100.0% Q1 2026
Siren, L.L.C. · Added
Change +1.9M Date Q1 2026
Siren, L.L.C. Added· Q1 2026 +1.9M Q1 2026
Janus Henderson Group PLC · Exited
Change −1.9M Δ Own −100.0% Date Q1 2026
Janus Henderson Group PLC Exited· Q1 2026 −1.9M −100.0% Q1 2026
Balyasny Asset Management L.P. · New
Change +1.1M Date Q1 2026
Balyasny Asset Management L.P. New· Q1 2026 +1.1M Q1 2026
Vestal Point Capital, LP · Added
Change +1.1M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +1.1M Q1 2026
Blue Owl Capital Holdings LP · Added
Change +1.1M Date Q1 2026
Blue Owl Capital Holdings LP Added· Q1 2026 +1.1M Q1 2026
Eventide Asset Management, LLC · Exited
Change −950K Δ Own −100.0% Date Q1 2026
Eventide Asset Management, LLC Exited· Q1 2026 −950K −100.0% Q1 2026
Braidwell LP · Reduced
Change −674K Date Q1 2026
Braidwell LP Reduced· Q1 2026 −674K Q1 2026
Morgan Stanley · Reduced
Change −632K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −632K Q1 2026
Millennium Management LLC · Reduced
Change −540K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −540K Q1 2026
Point72 Asset Management, L.P. · Reduced
Change −388K Δ Own −69.1% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −388K −69.1% Q1 2026
Kennedy Capital Management LLC · Added
Change +349K Date Q1 2026
Kennedy Capital Management LLC Added· Q1 2026 +349K Q1 2026
Birchview Capital, LP · New
Change +250K Date Q1 2026
Birchview Capital, LP New· Q1 2026 +250K Q1 2026
FMR LLC · New
Change +232K Date Q1 2026
FMR LLC New· Q1 2026 +232K Q1 2026
Nextech Invest, Ltd. · Added
Change +200K Date Q1 2026
Nextech Invest, Ltd. Added· Q1 2026 +200K Q1 2026
Data through Q1 2026 · filed May 29, 2026
15 of 54

Famous investor activity in enGene Holdings Inc. (ENGN)

enGene Holdings Inc. (ENGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Astley-Sparke Philip · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Astley-Sparke Philip Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Brunk Gerald A. · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Brunk Gerald A. Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Glickman Richard M. · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Glickman Richard M. Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Grossman William · Director 2 operations 231K
Owned 200K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Grossman William Director 2 operations 231K 200K Jun 16, 2026 Jun 17, 2026
Hastings Paul J. · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Hastings Paul J. Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Heffernan Michael Thomas · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Heffernan Michael Thomas Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Joustra Wouter · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Joustra Wouter Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Zoth Lota S. · Director Grant (A) 31K
Owned 31K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Zoth Lota S. Director Grant (A) 31K 31K Jun 16, 2026 Jun 17, 2026
Cheung Anthony Tzeyew · Officer Grant (A) 195K
Owned 195K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Cheung Anthony Tzeyew Officer Grant (A) 195K 195K Jan 30, 2026 Feb 3, 2026
Giguere Lee · Officer Grant (A) 195K
Owned 195K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Giguere Lee Officer Grant (A) 195K 195K Jan 30, 2026 Feb 3, 2026
Nichols Alexander Julian · Officer Grant (A) 195K
Owned 195K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Nichols Alexander Julian Officer Grant (A) 195K 195K Jan 30, 2026 Feb 3, 2026
Daws D. Ryan · Officer Grant (A) 220K
Owned 220K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Daws D. Ryan Officer Grant (A) 220K 220K Jan 30, 2026 Feb 3, 2026
Cooper Ronald Harold Wilfred · Director, Officer Grant (A) 801K
Owned 801K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Cooper Ronald Harold Wilfred Director, Officer Grant (A) 801K 801K Jan 30, 2026 Feb 3, 2026
Connolly Joan · Officer Grant (A) 195K
Owned 195K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Connolly Joan Officer Grant (A) 195K 195K Jan 30, 2026 Feb 3, 2026
Boyd Matthew Ross · Officer Grant (A) 195K
Owned 195K Trade date Jan 30, 2026 Filed date Feb 3, 2026
Boyd Matthew Ross Officer Grant (A) 195K 195K Jan 30, 2026 Feb 3, 2026
15 of 17
15 of 17 Sign in to continue to older insider transactions.

enGene Holdings Inc. (ENGN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Forbion Growth Sponsor Feac I B.V. 5.5M
% of shares outstanding 10.4% Filing date Nov 1, 2024
Forbion Growth Sponsor Feac I B.V. 5.5M 10.4% Nov 1, 2024
Bml Investment Partners, L.P. 6.7M
% of shares outstanding 9.9% Filing date May 14, 2026
Bml Investment Partners, L.P. 6.7M 9.9% May 14, 2026
Venrock Healthcare Capital Partners Iii, L.P. 3.6M
% of shares outstanding 8.1% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 3.6M 8.1% Nov 14, 2024
Blue Owl Capital Holdings LP 3.1M
% of shares outstanding 7.0% Filing date Nov 14, 2024
Blue Owl Capital Holdings LP 3.1M 7.0% Nov 14, 2024
Invus Public Equities, L.P. 4.5M
% of shares outstanding 6.7% Filing date May 5, 2026
Invus Public Equities, L.P. 4.5M 6.7% May 5, 2026
Foresite Capital Fund VI LP 2.5M
% of shares outstanding 5.8% Filing date Feb 23, 2024
Foresite Capital Fund VI LP 2.5M 5.8% Feb 23, 2024
Adage Capital Management, L.P. 2.3M
% of shares outstanding 5.3% Filing date Nov 12, 2024
Adage Capital Management, L.P. 2.3M 5.3% Nov 12, 2024
Deep Track Capital, LP
% of shares outstanding 5.2% Filing date Feb 23, 2024
Deep Track Capital, LP 5.2% Feb 23, 2024
8 of 13

enGene Holdings Inc. (ENGN) ownership FAQ

Who owns ENGN?

54 reporting institutions disclosed ENGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.